OR WAIT null SECS
Syngene International appoints two US-based executives to senior level positions.
Syngene International announced the appointment of two senior level positions. Alex Del Priore will serve as the senior vice president of Manufacturing Services, while Alan Collis will become the vice president of Integrated Drug Services. Both Del Priore and Collis are based out of the United States, an area the company has identified as a key market.
Del Priore has spent two decades in development, commercialization, and life-cycle management of products in the life sciences market. As a member of the executive committee, he will provide strategic insight into the growth of the company’s manufacturing services businesses. He will manage API growth outcomes concerning their Mangalore facility as well as the company’s large-molecule operations.
Collis is a drug discovery and development scientist specializing in discovery, preclinical, and early clinical studies who has led 33 novel small molecules into preclinical evaluation. He will oversee formulation and operation of Syngene’s integrated drug discovery plan at Synvent, the company’s platform for integrated discovery and early development of novel molecules.
"As we continue our rapid growth in the global CRO/CDMO marketplace, these hires align with Syngene's focus on providing end-to-end solutions for discovery, development, and manufacturing across a range of therapeutic areas and modalities.” said Jonathan Hunt, CEO and managing director at Syngene International, in a company press release. “We look forward to having Alex and Alan on board, which will help strengthen our position as a partner in innovation for our clients and to steer Syngene towards new growth milestones."